| Literature DB >> 33815196 |
Li Gu1, Yiyao Wang1, Lei Feng1, Saiqun Li1, Mengwei Zhang1, Qingqing Ye1, Yijing Zhuang1, Zhong-Lin Lu2,3,4, Jinrong Li1, Jin Yuan1.
Abstract
Previous studies have demonstrated that orientation-specific deprivation in early life can lead to neural deficits of spatial vision in certain space, and can even result in meridional amblyopia (MA). Individuals with astigmatism are the optimal and natural models for exploring this asymmetric development of spatial vision in the human visual system. This study aims to assess the contrast sensitivity function (CSF) and EEG signals along two principal meridians in participants with regular astigmatism when being optimal optical corrected. Twelve participants with astigmatism (AST group, 20 eyes) and thirteen participants with (MA group, 19 eyes) were recruited in the current study. CSFs and spatial sweep visual evoked potentials (sVEP) were measured with vertical and horizontal sinewave gratings along two principal meridians monocularly. Area under log CSF (AULCSF), spatial frequency threshold corresponding to 80% contrast gratings (SF threshold at 80% ctr), and CSF acuity were calculated from CSF test. In addition, sVEP amplitudes and thresholds were calculated with the recursive least square method. Participants with astigmatism exhibited marked vertical-horizontal resolution disparities even after they were corrected with optimal optical corrections. CSF tests showed that AULCSF along weak meridian (measured with horizontal gratings) was lower than that along strong meridian (measured with vertical gratings) in both groups. Significant meridional disparity of CSF acuity was also found in both groups. In addition, the MA group showed larger meridional disparity compared to the AST group. Spatial sVEP thresholds also supported the existence of marked meridional disparity. Our results suggest that meridian-specific partial deprivation in early life might lead to monocularly asymmetric development of spatial vision in the human visual system. In terms of application, we tested the feasibility and reliability of adopting psychophysical and EEG scalings to investigate the asymmetric development of spatial vision related to astigmatism. These paradigms are potentially applicable to reduce and even eliminate the meridional disparity in the primary visual cortex by adopting perceptual learning or other vision-related interventions.Entities:
Keywords: astigmatism; contrast sensitivity; meridional amblyopia; sVEP; spatial vision
Year: 2021 PMID: 33815196 PMCID: PMC8010696 DOI: 10.3389/fpsyg.2021.595536
Source DB: PubMed Journal: Front Psychol ISSN: 1664-1078
Summary of the refractive profile of MA and AST groups in this study showing the mean refractive error (in DS and DC), power range (in DS and DC), spherical equivalent (in D), the refractive and occlusion history of the participants.
| AST | MA | |
| N | 10 (20 eyes);3/10 astigmatism with anisometropia | 13 (19 eyes);6/13 meridional amblyopia with anisometropia |
| Age | Mean 9.10 ± 1.37 | Mean 13.08 ± 6.75 |
| median 9 | median 11 | |
| age range 8–12 | age range 7–26 | |
| BCVA | OD −0.00 ± 0.04 | OD 0.22 ± 0.10 |
| OS 0.01 ± 0.04 | OS 0.16 ± 0.06 | |
| VA | OD 0.31 ± 0.19 | OD 0.50 ± 0.21 |
| OS 0.34 ± 0.23 | OS 0.41 ± 0.14 | |
| Mean refractive error (DS/DC) | OD + 1.15 DS/−3.08 DC | OD + 1.78 DS/−3.56 DC |
| OS + 1.03 DS/−3.13 DC | OS + 1.66 DS/−3.30 DC | |
| Power range (DS/DC) | OD −2.50 to + 2.50 DS/−6.00 to −1.75 DC | OD −3.75 to + 6.50 DS/−5.50 to −1.50 DC |
| OS −2.75 to + 2.75 DS/−6.00 to −1.50 DC | OS −4.00 to + 5.75 DS/−6.00 to −2.00 DC | |
| Spherical equivalent (mean ± SD) | OD 0 ± 3.51 D | OD −0.39 ± 1.41 D |
| OS 0.01 ± 3.29 D | OS −0.54 ± 1.69 D | |
| Refractive history | Current spectacle wearers | Current spectacle wearers |
| Occlusion history | N.A. | 5/13 were treated with patching therapy (3.89 ± 1.79 years) |
FIGURE 1Experimental flowchart. We measured the CSF and sVEP signals along two principal meridians (i.e., horizontal meridian and vertical meridian, to match the distribution of with-the-rule astigmatic subjects in the study) monocularly in all participants. N indicates the number of eyes. See also Supplementary Table 1 for clinical details.
Mean values of sVEP threshold, amplitudes at target frequency (12 Hz), and CSF tests along two meridians.
| Strong meridian | Weak meridian | Difference | |||
| (Mean ± SE) | (Mean ± SE) | (Mean ± SE) | |||
| Threshold ( | 19.201 ± 0.675 | 16.621 ± 0.569 | 2.580 ± 0.881 | 2.928 | 0.013* |
| sf1(2 cpd) | 4.235 ± 0.362 | 3.580 ± 0.500 | 0.292 ± 0.814 | 0.359 | 0.729 |
| sf2(3.6 cpd) | 3.539 ± 0.288 | 3.274 ± 0.254 | 0.362 ± 0.190 | 1.907 | 0.073 |
| sf3(5.1 cpd) | 4.211 ± 0.379 | 2.997 ± 0.273 | 1.214 ± 0.258 | 4.713 | < 0.001** |
| sf4(6.7 cpd) | 4.096 ± 0.391 | 2.909 ± 0.244 | 1.265 ± 0.298 | 4.240 | < 0.001** |
| sf5(8.2 cpd) | 3.857 ± 0.394 | 2.898 ± 0.192 | 0.921 ± 0.372 | 2.475 | 0.024* |
| sf6(9.8 cpd) | 3.276 ± 0.307 | 2.303 ± 0.192 | 1.051 ± 0.298 | 3.529 | 0.002* |
| sf7(11.3 cpd) | 2.909 ± 0.258 | 2.385 ± 0.164 | 0.586 ± 0.309 | 1.896 | 0.076 |
| sf8(12.9 cpd) | 2.304 ± 0.183 | 2.269 ± 0.172 | 0.092 ± 0.231 | 0.396 | 0.697 |
| sf9(14.4 cpd) | 2.214 ± 0.201 | 2.230 ± 0.124 | 0.096 ± 0.181 | 0.529 | 0.605 |
| sf10(16 cpd) | 2.080 ± 0.111 | 2.262 ± 0.197 | −0.272 ± 0.224 | –1.216 | 0.243 |
| Threshold ( | 17.113 ± 0.634 | 14.803 ± 0.529 | 2.310 ± 0.610 | 3.789 | 0.002* |
| sf1(2 cpd) | 3.997 ± 0.432 | 4.558 ± 0.356 | −1.453 ± 0.512 | –2.835 | 0.025* |
| sf2(3.6 cpd) | 3.524 ± 0.293 | 3.018 ± 0.149 | 0.506 ± 0.292 | 1.735 | 0.100 |
| sf3(5.1 cpd) | 3.834 ± 0.379 | 2.911 ± 0.193 | 0.923 ± 0.362 | 2.552 | 0.020* |
| sf4(6.7 cpd) | 3.859 ± 0.338 | 2.655 ± 0.193 | 1.204 ± 0.293 | 4.111 | 0.001* |
| sf5(8.2 cpd) | 3.480 ± 0.352 | 2.376 ± 0.204 | 1.104 ± 0.289 | 3.826 | 0.001* |
| sf6(9.8 cpd) | 3.123 ± 0.383 | 2.149 ± 0.198 | 1.050 ± 0.376 | 2.791 | 0.013* |
| sf7(11.3 cpd) | 2.823 ± 0.388 | 2.082 ± 0.163 | 0.741 ± 0.378 | 1.959 | 0.066 |
| sf8(12.9 cpd) | 2.439 ± 0.253 | 1.968 ± 0.173 | 0.450 ± 0.231 | 1.951 | 0.068 |
| sf9(14.4 cpd) | 2.024 ± 0.207 | 1.937 ± 0.176 | 0.103 ± 0.243 | 0.422 | 0.679 |
| sf10(16 cpd) | 2.360 ± 0.207 | 1.977 ± 0.173 | 0.256 ± 0.218 | 1.176 | 0.261 |
| SF threshold | 41.919 ± 2.786 | 34.681 ± 2.114 | 7.238 ± 2.829 | 2.558 | 0.019* |
| AULCSF | 1.574 ± 0.050 | 1.411 ± 0.054 | 0.163 ± 0.032 | 5.030 | < 0.001** |
| CSF acuity | 1.642 ± 0.028 | 1.565 ± 0.026 | 0.077 ± 0.033 | 2.362 | 0.029* |
| 0.5 cpd | 1.212 ± 0.029 | 1.153 ± 0.048 | 0.059 ± 0.038 | 1.563 | 0.135 |
| 1 cpd | 1.473 ± 0.033 | 1.443 ± 0.035 | 0.031 ± 0.025 | 1.212 | 0.240 |
| 2 cpd | 1.626 ± 0.043 | 1.558 ± 0.038 | 0.068 ± 0.040 | 1.718 | 0.102 |
| 4 cpd | 1.648 ± 0.057 | 1.454 ± 0.070 | 0.194 ± 0.056 | 3.464 | 0.003* |
| 8 cpd | 1.446 ± 0.056 | 1.227 ± 0.071 | 0.219 ± 0.049 | 4.444 | < 0.001** |
| 12 cpd | 1.245 ± 0.070 | 1.097 ± 0.079 | 0.149 ± 0.065 | 2.287 | 0.034* |
| 16 cpd | 0.859 ± 0.065 | 0.686 ± 0.050 | 0.173 ± 0.065 | 2.667 | 0.015* |
| SF threshold | 32.107 ± 3.014 | 21.949 ± 1.478 | 10.158 ± 2.143 | 4.740 | < 0.001** |
| AULCSF | 1.397 ± 0.066 | 1.113 ± 0.077 | 0.284 ± 0.028 | 10.209 | < 0.001** |
| CSF acuity | 1.508 ± 0.042 | 1.370 ± 0.026 | 0.138 ± 0.029 | 4.707 | < 0.001** |
| 0.5 cpd | 1.238 ± 0.053 | 1.185 ± 0.036 | 0.052 ± 0.037 | 1.400 | 0.178 |
| 1 cpd | 1.426 ± 0.047 | 1.343 ± 0.041 | 0.083 ± 0.033 | 2.554 | 0.020 |
| 2 cpd | 1.604 ± 0.042 | 1.351 ± 0.078 | 0.253 ± 0.050 | 5.060 | < 0.001** |
| 4 cpd | 1.512 ± 0.063 | 1.232 ± 0.085 | 0.280 ± 0.043 | 6.505 | < 0.001** |
| 8 cpd | 1.212 ± 0.093 | 0.968 ± 0.087 | 0.243 ± 0.052 | 4.717 | < 0.001** |
| 12 cpd | 0.960 ± 0.083 | 0.650 ± 0.087 | 0.310 ± 0.058 | 5.337 | < 0.001** |
| 16 cpd | 0.624 ± 0.090 | 0.313 ± 0.057 | 0.311 ± 0.045 | 6.946 | < 0.001** |
FIGURE 2CSF results along two meridians. Participants showed meridional disparity in the AST group (A) and MA group (B). Error bars stand for ± S.E.M.
FIGURE 3Meridional disparity of AULCSF in the AST group (A) and the MA group (B). Error bars represent ± S.E.M. Two asterisks ** indicate a significance level of p < 0.001.
FIGURE 4Meridional disparity of CSF acuity in the AST group (A) and the MA group (B). Error bars represent ± S.E.M. An asterisk * indicates a significance level of p < 0.05. Two asterisks ** indicate a significance level of p < 0.001.
FIGURE 5Spatial sVEP voltage response at the second harmonic of the test stimulus reversal rate is plotted as a function of spatial frequency of the test stimulus in the AST group (A) and the MA group (B). Error bars represent ± S.E.M.
FIGURE 6A scatter plot of CSF and sVEP measures. (A) SF threshold at 80% ctr and the sVEP threshold in the AST group; (B) meridional disparity of SF threshold at 80% ctr and meridional disparity of the sVEP threshold in the AST group; (C) SF threshold at 80% ctr and the sVEP threshold in the MA group; and (D) meridional disparity of SF threshold at 80% ctr and meridional disparity of the sVEP threshold in the MA group. An asterisk * indicates a significance level of p < 0.05. Two asterisks ** indicate a significance level of p < 0.001.